Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
UDoTest logo — Empowering proactive health with early disease detection thr...

UDoTest

Empowering proactive health with early disease detection through accessible self-sampling screening.

Founded 2017 11-50 employees Non Equity Assistance B2B, Health Care +3

General Information

Company Name UDoTest
Founded Year 2017
Founders / Decision Makers
Team member
Employees 11-50
Industries B2B, Health Care, Health and Wellness +2
Funding Stage Non Equity Assistance
Social

Get notified when UDoTest moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About UDoTest

UDoTest is a B2B disease testing SaaS platform that aims to revolutionize proactive health by facilitating early disease detection through accessible self-sampling screening. The company, founded in 2017 by Allison Martin and based in Boston, Massachusetts, focuses on bridging screening gaps, enhancing the wellness experience, and improving quality through a human-centered approach. The platform's self-sampling test kits are tailored for conducting colon cancer and other health screenings, ultimately enabling early disease detection. In October 2020, MassChallenge made a Non-Equity Assistance investment in the company, indicating the confidence of investors in UDoTest's mission and potential within the Healthcare and SaaS industries. This demonstrates the company's ability to attract support from reputable sources as it continues to develop its innovative solution for proactive health management.

Taxonomy: B2B platform, disease testing, self-sampling, early disease detection, wellness experience, colon cancer screening, health screening, preventative screening, medical testing, healthcare access, mobile health, Boston, Massachusetts

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
21 Oct 2020
Seed Round •••••• 1
Investor
01 Jan 2020

UDoTest Alternatives & Competitors

UDoTest vs
Vasolabs, Inc.
Vasolabs, Inc. United States

Take charge of your heart health now!

17 employees
Health Care
UDoTest vs
SelectWell
SelectWell United States

HELPING EMPLOYERS REDUCE HEALTHCARE COSTS WHILE IMPROVING EMPLOYEE WELL-BEING

11 employees
Health Care, Health and Wellness
UDoTest vs
ROBOSCIENTIFIC LIMITED
ROBOSCIENTIFIC LIMITED United Kingdom

VOC Sensing on-farm detecting disease in livestock and crops. VOC Analysers for use in labs or in th...

5 employees

FAQ About UDoTest

Empowering proactive health with early disease detection through accessible self-sampling screening.
UDoTest was founded in 2017.
UDoTest operates in the following industries: B2B, Health Care, Health and Wellness, SaaS, Sports.
UDoTest has approximately 11-50 employees.
UDoTest has completed 2 funding rounds. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to UDoTest include Vasolabs, Inc., SelectWell, ROBOSCIENTIFIC LIMITED, AeenaDx, Neuwell®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
UDoTest and Vasolabs, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors UDoTest and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy